The influence of heparin on the immunochemical evaluation of antithrombin IIi by electroimmunoassay
Gandolfo, G.M.; Torresi, M.V.
Haematologica 63(5): 512-520
1978
ISSN/ISBN: 0390-6078 PMID: 107070 Document Number: 138946
Document emailed within 1 workday
Related Documents
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92Levy, S.W.; Jaques, L.B. 1978: Appearance of heparin antithrombin-active chains in vivo after injection of commercial heparin and in anaphylaxis Thrombosis Research 13(3): 429-441
Gouault-Heilmann, M.; Contant, G.; Pochmalicki, G.; Jan, F. 1984: Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin IIi Presse Medicale 13(22): 1393-1394
Kondo, S.; Niwa, M. 1985: Antithrombin IIi and heparin cofactor Ii Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 61: 106-113
Nakagawa, M.; Okada, T.; Okuda, S.; Nishizawa, A.; Watada, M. 1977: Exogenous heparin and antithrombin activity Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 40(2): 207-212
Mach, U.; Puzyna, W. 1987: Effect of heparin treatment on antithrombin IIi (AT III) activity Ginekologia Polska 58(8): 544-547
Aiach, M.; Fiessinger, J.N.; Andreux, J.P.; Beuvin, J.; Housset, E.; Leclerc, M. 1977: Electrophoretic mobility of antithrombin IIi in an agarose gel with heparin Pathologie-Biologie 25 Suppl: 35-41
Riensenfeld, J.; Höök, M.; Björk, I.; Lindahl, U.; Ajaxon, B. 1977: Structural requirements for the interaction of heparin with antithrombin IIi Federation Proceedings 36(1): 39-43
Okajima, K.; Ueyama, H.; Hashimoto, Y.; Sasaki, Y.; Matsumoto, K.; Okabe, H.; Inoue, M.; Araki, S.; Takatsuki, K. 1989: Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto Thrombosis and Haemostasis 61(1): 20-24
Melissari, E.; Thye, C.; Scully, M.F.; Kakkar, V.V. 1989: Influence of whole blood on standard curve for heparin measurement--possible heparin binding by red cells Thrombosis and Haemostasis 61(2): 262-265
Mätzsch, T.; Bergqvist, D.; Blomquist, P.; Jiborn, H. 1987: Influence of standard heparin or low molecular weight heparin on healing of abdominal wounds and colonic anastomoses in rats Acta Chirurgica Scandinavica 153(10): 593-598
Mortensen, S.A.; Remvig, L.; Als, O.S.; Andreasen, T. 1983: Antithrombin IIi (AT-III) and low dosage heparin therapy. the prognostic value of AT-IIi in acute myocardial infarction Ugeskrift for Laeger 145(14): 1056-1059
Dietrich, W.; Schroll, A.; Göb, E.; Barankay, A.; Richter, J.A. 1984: Antithrombin IIi substitution for optimization of the heparin effect during extracorporeal circulation in heart surgery Der Anaesthesist 33(9): 422-427
Daly, M.; Ball, R.; O'Meara, A.; Hallinan, F.M. 1989: Identification and characterisation of an antithrombin III mutant (AT Dublin 2) with marginally decreased heparin reactivity Thrombosis Research 56(4): 503-513
Psuja, P. 1988: Effect of antithrombin IIi on the binding of heparin and its low molecular weight fraction CY 216 with endothelium in vitro Acta Haematologica Polonica 19(3-4): 143-149
Bergmann, H.; Blauhut, B.; Necek, S.; Kramar, H.; Vinazzer, H. 1980: Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin IIi Der Anaesthesist 29(11): 623-626
Scully, M.F.; Ellis, V.; Kakkar, V.V. 1986: Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation Thrombosis Research 41(4): 489-499
Francis, C.W.; Pellegrini, V.D.; Marder, V.J.; Harris, C.M.; Totterman, S.; Gabriel, K.R.; Baughman, D.J.; Roemer, S.; Burke, J.; Goodman, T.L. 1989: Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40 Journal of Bone and Joint Surgery. American Volume 71(3): 327-335
Pislaru, S.V.; Pislaru, C.; Zhu, X.; Arnout, J.; Stassen, T.; Vanhove, P.; Herbert, J.M.; Meuleman, D.G.; Van de Werf, F. 1998: Comparison of a synthetic antithrombin III-binding pentasaccharide and standard heparin as an adjunct to coronary thrombolysis Thrombosis and Haemostasis 79(6): 1130-1135
Zhang, L.; Zhang, G. 1999: Thrombosis induced by homocysteine does not depend on platelet aggregation or heparin cofactor's antithrombin activity Hunan Yi Ke da Xue Xue Bao 24(4): 309